The Shortcomings of COVID-19 Testing in Ecuador: Time to Incentivize Research and Innovation

Izan Chalen; María Mercedes Cobo; Bernardo Gutierrez; Andrés Carrazco-Montalvo; Patricio Ponce; Diego F. Cisneros-Heredia

doi:10.3390/life12030325

The Shortcomings of COVID-19 Testing in Ecuador: Time to Incentivize Research and Innovation

Izan Chalen^*
, María Mercedes Cobo
, Bernardo Gutierrez
, Andrés Carrazco-Montalvo
, Patricio Ponce
, Diego F. Cisneros-Heredia^*

^*Corresponding author for this work

University of Illinois at Urbana-Champaign
University of Oxford Medical Sciences Division
Universidad San Francisco de Quito
University of Oxford
Instituto Nacional de Investigación en Salud Pública

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

The COVID-19 pandemic hit Ecuador severely. The country caught the attention of international media due to its high death toll and overwhelmed healthcare system. The clinical diagnostics system was rapidly overloaded, and the import of PCR tests was delayed. The case of Ecuador illustrates how middle-income countries rely heavily on the importation of biotechnological products for their healthcare systems. The Ecuadorian experience during the COVID-19 pandemic serves as a call for the formation of policies for the development of the biotechnological industry.

Original language	English
Article number	325
Journal	Life
Volume	12
Issue number	3
DOIs	https://doi.org/10.3390/life12030325
State	Published - Mar 2022

Keywords

Biotechnology industry
Coronavirus
Diagnosis
Research and development

Access to Document

10.3390/life12030325

Cite this

@article{2358ded5f39246a6b565fd9fda9154ba,

title = "The Shortcomings of COVID-19 Testing in Ecuador: Time to Incentivize Research and Innovation",

abstract = "The COVID-19 pandemic hit Ecuador severely. The country caught the attention of international media due to its high death toll and overwhelmed healthcare system. The clinical diagnostics system was rapidly overloaded, and the import of PCR tests was delayed. The case of Ecuador illustrates how middle-income countries rely heavily on the importation of biotechnological products for their healthcare systems. The Ecuadorian experience during the COVID-19 pandemic serves as a call for the formation of policies for the development of the biotechnological industry.",

keywords = "Biotechnology industry, Coronavirus, Diagnosis, Research and development",

author = "Izan Chalen and Cobo, \{Mar{\'i}a Mercedes\} and Bernardo Gutierrez and Andr{\'e}s Carrazco-Montalvo and Patricio Ponce and Cisneros-Heredia, \{Diego F.\}",

note = "Publisher Copyright: {\textcopyright} 2022 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2022",

month = mar,

doi = "10.3390/life12030325",

language = "Ingl{\'e}s",

volume = "12",

journal = "Life",

issn = "2075-1729",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "3",

}

TY - JOUR

T1 - The Shortcomings of COVID-19 Testing in Ecuador

T2 - Time to Incentivize Research and Innovation

AU - Chalen, Izan

AU - Cobo, María Mercedes

AU - Gutierrez, Bernardo

AU - Carrazco-Montalvo, Andrés

AU - Ponce, Patricio

AU - Cisneros-Heredia, Diego F.

PY - 2022/3

Y1 - 2022/3

N2 - The COVID-19 pandemic hit Ecuador severely. The country caught the attention of international media due to its high death toll and overwhelmed healthcare system. The clinical diagnostics system was rapidly overloaded, and the import of PCR tests was delayed. The case of Ecuador illustrates how middle-income countries rely heavily on the importation of biotechnological products for their healthcare systems. The Ecuadorian experience during the COVID-19 pandemic serves as a call for the formation of policies for the development of the biotechnological industry.

AB - The COVID-19 pandemic hit Ecuador severely. The country caught the attention of international media due to its high death toll and overwhelmed healthcare system. The clinical diagnostics system was rapidly overloaded, and the import of PCR tests was delayed. The case of Ecuador illustrates how middle-income countries rely heavily on the importation of biotechnological products for their healthcare systems. The Ecuadorian experience during the COVID-19 pandemic serves as a call for the formation of policies for the development of the biotechnological industry.

KW - Biotechnology industry

KW - Coronavirus

KW - Diagnosis

KW - Research and development

UR - https://www.scopus.com/pages/publications/85125483589

U2 - 10.3390/life12030325

DO - 10.3390/life12030325

M3 - Artículo

AN - SCOPUS:85125483589

SN - 2075-1729

VL - 12

JO - Life

JF - Life

IS - 3

M1 - 325

ER -

The Shortcomings of COVID-19 Testing in Ecuador: Time to Incentivize Research and Innovation

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this